| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Development Officer | See Remarks
1 company
Michaelson Jennifer is a Chief Scientific Officer at Cullinan Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $1.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 5, 2024 | CGEM Cullinan Therapeutics, Inc. | Chief Scientific Officer | Sell | 8,000 | $16.33 | $130,640.00 | -6.1% | -0.5% | -54.1% | |
| May 7, 2024 | CGEM Cullinan Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 63,606 | $28.25 | $1,796,675.80 | -13.5% | -40.2% | -73.8% | |
| Dec 21, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Scientific Officer | Sell | 1,145 | $8.50 | $9,732.50 | -1.3% | +63.8% | +22.4% | |
| Dec 18, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Scientific Officer | Sell | 238 | $8.22 | $1,956.36 | -0.3% | +67.8% | +25.8% | |
| Dec 12, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Scientific Officer | Sell | 1,068 | $7.81 | $8,341.08 | -1.2% | +103.7% | +58.7% | |
| Jun 20, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Development Officer | Sell | 238 | $12.94 | $3,079.72 | -0.3% | -23.1% | +34.0% | |
| Jun 12, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Development Officer | Sell | 176 | $13.11 | $2,307.36 | -0.2% | -16.8% | +82.9% | |
| Jun 7, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Development Officer | Sale+OE | 12,000 | $12.31 | $147,729.00 | -6.2% | -16.2% | +68.1% | |
| May 18, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Development Officer | Sell | 239 | $8.76 | $2,093.64 | -0.3% | +13.9% | +163.3% | |
| May 12, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Development Officer | Sell | 193 | $8.78 | $1,694.54 | -0.2% | +5.4% | +172.2% |